© 2020 MJH Life Sciences™ and Managed Healthcare Executive. All rights reserved.
Expert Interviews
Anti-VEGF Therapy for Diabetic Retinopathy Gets to the Root Cause
September 14, 2020
Drugs block the formation of tiny blood vessels in the retina that are prone to breaking open, resulting in bleeds that can cause serious vision impairment and blindness, explains ADA chief scientific and medical officer, Robert Gabbay, in this part four of four video series.
ADA's Dr. Robert Gabbay Discusses Patient, System Challenges to Eyecare
September 13, 2020
Less than half of Americans with diabetes get annual eye exams, says Robert Gabbay, M.D.,Ph.D., FACP, in this part three of four video series. Gabbay became chief scientific and medical officer for the American Diabetes Association this summer.
Diabetes Drugs and Retinopathy: So Far, It's All About Lowering A1C Level
September 12, 2020
In this part two of four video series, ADA Chief Science and Medical Officer Robert Gabbay, MD, PhD, FACP, says data showing kidney benefits of SGLT2 inhibitors may indicate protection against retinopathy but research is needed.
Diabetes Can Lead to Leaky Retinal Blood Vessels, Sudden Blindness
September 11, 2020
The American Diabetes Association and other groups are mounting a public health campaign to encourage people with diabetes to get annual eye exams. ADA Chief Scientific and Medical Officer Robert Gabbay, MD, PhD, FACP, explains "leaky blood vessels" and diabetic retinopathy in this part one of four video series.
Secondary Progressive Multiple Sclerosis: Overview
September 11, 2020
Thomas P. Leist, MD, PhD, describes the different forms of MS and how patients accumulate new disability when they advance to secondary progressive MS.
Classification and Terminology in Secondary Progressive Multiple Sclerosis
September 11, 2020
Fred Lublin, MD, discusses the vital information that’s needed to optimally characterize MS.
Covid As an Accelerant: On Value-based Care (Yes), On Telemedicine (Partly), on AI (Not So Much)
September 05, 2020
Brent James discusses the long-term consequences of COVID-19.
Leaders of COVID-19 Failed To See the ‘Whole Picture’
September 04, 2020
Brent James, M.D., M.Stat., the quality and patient safety expert, finds fault with singular focus on COVID-19. Watch James' interview in this part two of three video series.
Balance Lacking in the COVID-19 Response
September 03, 2020
Brent James, the quality and patient safety expert, sees excess mortality from lack of care for life-threatening conditions other than COVID-19. Watch James' interview in this part one of three video series.
2021 Health Insurance Rates Generally Flat, Even Decreasing
August 29, 2020
Georgetown’s Sabrina Corlette says the 2021 rates were calculated before the recent announcements about COVID-19 premium relief in this part two of two video series.